CHARLOTTE, NC
Alopecia and Hair Loss Clinical Trials
4 studies are enrolling for hair loss near Charlotte NC right now. Notably, two take children, one takes women only, and one gives no drug at all. You may be compensated for your time, and no insurance is needed.
4
Open Near Charlotte
6
Youngest Age Taken
+/- $100
Per Visit
New here? Read how this page works
First, two things decide which of these will take you, and they are your age and which kind of hair loss you have. So here is the order to work through.
- Ask for your SALT score in writing. Because it is the percentage of scalp with hair missing, and most studies want 50 or more before they will look at you.
- Work out which kind of hair loss you have. Notably, smooth round patches and gradual thinning are different conditions with different studies and different drugs.
- Ask for a thyroid and iron blood test. In fact, both cause shedding, and both are easy to miss and easy to treat.
- Finally, tap the button. Then we check you against every study we track and tell you when a new one opens.
Of course, checking never signs you up for anything. You are only seeing where you might fit.
The 4 Studies Enrolling Near Charlotte Right Now
All four are open today. However, they take very different people, so read which is which before you call.
The two for children and teenagers
Both test a tablet already approved for adults. Notably, nothing at all is approved for under 18s yet, which is what these exist to change.
Down to Age Six, With an Approved Drug
Eli Lilly / Late stage tablet
Baricitinib is a daily tablet, and it was the first drug ever approved for severe patchy hair loss in adults. This study takes it down into childhood. So it enrols from age six, which is the youngest on this page by some distance. Notably, hair regrowth in these studies is slow, and it is measured across a year rather than across weeks.
Payment is not published.
Check eligibility →More details
Why researchers are excited: this was the drug that broke the field open for adults in 2022. Meanwhile, nothing at all is approved for children.
Who this study is looking for
- Age 6 to 17
- Also, severe alopecia areata, usually meaning at least half the scalp
- Besides that, A SALT score confirming that, so ask for the number
- Finally, hair loss present for at least six months
Probably not a fit if: other causes of hair loss rule you out. Also, an active infection, or recent use of another JAK tablet. Notably, some blood test results at screening exclude you.
- Placebo group: Yes. There is a dummy group, and the split is not published.
- How long: Not published in full. However, regrowth in this field is measured across a year.
- Clinic visits: Not published on the public record.
- Phone calls: Not published on the public record.
- Most invasive part: Blood tests and scalp photographs. Also, a daily tablet, and a long commitment for a child.
- Setting: Outpatient.
- Where it runs: Dermatology Specialists of Charlotte, Charlotte NC 28277.
- Drive from Charlotte: This one is in south Charlotte, so no satellite town drive is involved.
- Two Charlotte sites share the same zip code, and one has closed. So ask for Dermatology Specialists of Charlotte by name, or you may be told it is finished.
- Full study record: View on ClinicalTrials.gov →
A Tablet for Teenagers, Already Approved for Adults
Sun Pharma / Late stage tablet
Deuruxolitinib is a twice daily tablet that blocks JAK enzymes. It is already approved for adults with severe patchy hair loss. So this study asks whether it works the same way in teenagers. Notably, that group usually waits years for access after adults get it. The site is in south Charlotte.
Payment is not published.
Check eligibility →More details
Why researchers are excited: teenagers are almost always last in line for a new treatment. Meanwhile, this is the age when hair loss does the most damage socially.
Who this study is looking for
- Age 12 to 17
- Also, alopecia areata with substantial scalp hair loss
- Besides that, A SALT score high enough to count as severe, so ask for that number
- Finally, able to swallow tablets twice a day
Probably not a fit if: a gene test can rule you out. People who process this drug slowly, called CYP2C9 poor metabolisers, are excluded. Also, other causes of hair loss, and recent use of another JAK tablet.
- Placebo group: Yes. There is a dummy group, and the split is not published.
- How long: Not published on the public record in full.
- Clinic visits: Not published on the public record.
- Phone calls: Not published on the public record.
- Most invasive part: Blood tests, including a gene test at screening. Also, scalp photographs and a tablet twice a day.
- Setting: Outpatient.
- Where it runs: Darst Dermatology, Charlotte NC 28277.
- Drive from Charlotte: This one is in south Charlotte, so no satellite town drive is involved.
- Ask about the gene test early. It is unusual, and it decides your entry before anything else does.
- Full study record: View on ClinicalTrials.gov →
The two for adults
These take different kinds of hair loss. So read which is which before you call, because they are not interchangeable.
For Pattern Hair Loss, Not Patchy Hair Loss
Veradermics / Mid stage tablet
This one is for female pattern hair loss, which is a different condition from the patchy kind. Here the hair thins gradually, usually along the parting, rather than falling out in circles. VDPHL01 is a tablet taken daily. Notably, it takes women only, aged 18 to 65. Two sites run it, at Huntersville and at Hickory.
Payment is not published.
Check eligibility →More details
Why researchers are excited: almost every drug for pattern hair loss was developed in men first. Meanwhile, women have far fewer approved options and are studied far less often.
Who this study is looking for
- Women aged 18 to 65
- Also, female pattern hair loss, meaning gradual thinning rather than patches
- Besides that, not currently taking a GLP-1 weight loss medicine
- Finally, willing to have small marker dots placed on the scalp
Probably not a fit if: a GLP-1 weight loss injection rules you out. That catches a lot of people right now. Also, the patchy kind of hair loss does not qualify here, because this is a different condition.
- Placebo group: Yes. There is a dummy group, and the split is not published.
- How long: Not published on the public record in full.
- Clinic visits: Not published on the public record.
- Phone calls: Not published on the public record.
- Most invasive part: Tiny marker dots tattooed on the scalp. Those let the same patch of scalp be photographed and counted each time. Also, blood tests and a daily tablet.
- Setting: Outpatient.
- Where it runs: Study site, Huntersville NC 28078; study site, Hickory NC 28602.
- Drive from Charlotte: Huntersville is about 25 minutes north, and Hickory about an hour north west.
- The scalp dots surprise people. They are small and permanent, and they exist so hair counts are measured in exactly the same spot. So ask to see one before you agree.
- Full study record: View on ClinicalTrials.gov →
A Registry That Follows People Already on Treatment
Pfizer / Observational registry
No drug is given here, and nothing is assigned. Researchers follow people who are already taking ritlecitinib, prescribed in the normal way. So this is about what happens in real life rather than in a trial. However, the study does not supply the drug. That means getting it through insurance is a separate hurdle you clear first.
Payment is not published.
Read the details →More details
Why researchers are excited: trials show what a drug does under ideal conditions. Meanwhile, a registry shows what it does for ordinary people over years.
Who this study is looking for
- Age 12 or over
- Also, alopecia areata
- Besides that, already prescribed ritlecitinib, or starting it through your own doctor
- Finally, willing to be followed over time
Probably not a fit if: any previous JAK tablet rules you out. So if you have tried baricitinib or another one, this is closed to you. Also, the study does not provide the drug, so insurance refusal ends it in practice.
- Placebo group: None at all. Nothing is assigned, because researchers only watch and record.
- How long: Long term follow up. The exact length is not published on the public record.
- Clinic visits: Not published on the public record.
- Phone calls: Not published on the public record.
- Most invasive part: Nothing beyond your normal care. So this is questionnaires and record keeping rather than procedures.
- Setting: Outpatient.
- Where it runs: Hickory Dermatology Research Center, Hickory NC 28602.
- Drive from Charlotte: Hickory is about an hour north west of the city on I-40.
- Sort the prescription first. The registry follows you, it does not supply the drug. So the insurance conversation comes before the research one.
- Full study record: View on ClinicalTrials.gov →
Not sure which one fits you?
First, answer a few quick health questions. Then we check you against all 4 at once. Also, no account and no paperwork.
See if I may fit one of these studies →What Is Actually Changing in Hair Loss Treatment
Three tablets were approved for severe patchy hair loss in four years, after decades of nothing.
Two Different Conditions Share One Word
Alopecia areata is an immune attack on the hair follicle, and it comes out in smooth round patches. Pattern hair loss is gradual thinning, usually along the parting or the crown. So they need different drugs and different studies. Notably, this page carries both, because people search for them the same way.
Ask for Your SALT Score By Name
SALT stands for Severity of Alopecia Tool, and it is the percentage of your scalp with hair missing. It runs from 0 to 100. Most studies want 50 or more, meaning at least half the scalp. So that single number decides which studies will even look at you, and most people have never been told theirs.
The Patchy Kind Is Not Caused by Stress Alone
People are often told it is stress, and then sent away. However, it is an immune condition, and the immune system attacks the follicle directly. So the follicle survives underneath, which is why regrowth is possible even after years. In fact, that is exactly what the newer drugs are aiming at.
2022 Changed Everything
Baricitinib was approved for severe patchy hair loss in June 2022. It was the first drug ever approved for the condition. Ritlecitinib followed in 2023 and deuruxolitinib in 2024. Meanwhile, before that the options were steroid injections into the scalp and not much else.
They All Block the Same Kind of Signal
All three are JAK inhibitors, which means they turn down the immune signals attacking the follicle. So they are tablets rather than creams or injections. However, they carry a boxed warning about heart and clot risks, which is why several studies here stop at 63 or 65.
Regrowth Is Slow, and That Is Normal
Hair grows about half an inch a month at best. So these studies measure success at six months and at a year, not at six weeks. Meanwhile, people often stop too early because nothing has visibly happened by month two. In fact, patience is part of the treatment here.
Eyebrows and Eyelashes Are Measured Separately
Many studies score them on their own scales, apart from the scalp. That matters, because losing them affects people more than the numbers suggest. So ask whether the study measures them. Also, ask what happens to your scores if only your scalp responds.
Pattern Hair Loss Has Its Own Small Field
Minoxidil and finasteride remain the mainstays, and both were developed largely in men. So women have fewer approved options and are studied far less often. Meanwhile, one study on this page takes women only for exactly that reason. In fact, that is the gap it exists to fill.
Hair Loss Help Near You
Ask a dermatologist for your SALT score, in writing, and ask which kind of hair loss you have. Also, ask whether anything on your blood tests explains it, because thyroid trouble and iron deficiency both cause shedding. Generally, your own doctor can run those first. Meanwhile, if you are on a weight loss injection, mention it, because it excludes you from some studies.
Research Sites Near Charlotte
Four research sites carry these studies, from south Charlotte up to Hickory. But sites add new studies all the time, so it is worth knowing what sits near you.
Atrium Health
Multiple Charlotte locations / 161+ active studies
Crohn’s, Heart Failure, COPD, Dementia, Type 2 Diabetes, Hypertension
Charlotte’s biggest health system. It is tied to Wake Forest University School of Medicine. Also, it runs far more trials than anyone else nearby.
Visit Website →
American Health Research Network
Ballantyne, NC 28277 / 25 to 30+ active studies
Asthma, COPD, Chronic Cough, Type 2 Diabetes
Led by Dr. Selwyn Spangenthal. It is the biggest private lung research group in Charlotte. Specifically, it has 4 offices: Charlotte, Rock Hill, Lake Norman, and Charleston.
Visit Website →
Monroe Biomedical Research
Monroe, NC / 17+ active studies
Asthma, COPD, Hypertension, Obesity, Ulcerative Colitis
Notably, one of the 5 busiest research sites in the country. Its 6,300 sq ft space can host overnight stays. It is also an SCRS Global Impact Partner.
Visit Website →
Clinical Research of Gastonia
Gastonia, NC / 11+ active studies
Asthma, COPD, Chronic Cough, Idiopathic Hypersomnia
Led by Dr. Anup Banerjee. Its 3,500 sq ft space sits next to CaroMont Regional Medical Center. Also, it has been running for over 10 years.
Visit Website →
OnSite Clinical Solutions
Ballantyne, NC 28277 / 10+ active studies
Ulcerative Colitis, Crohn’s, COPD, Heart Failure, Atopic Dermatitis
It works with Charlotte doctors in heart, gut, skin, nerve, and joint care. Besides, it runs studies from Phase I through Phase IV.
Visit Website →
Flourish Research
Matthews, NC 28105 / 4+ active studies
Alzheimer’s Disease, Early Alzheimer’s, Alzheimer’s-Related Psychosis
Led by Dr. M. Reza Bolouri. He has 20+ years in Alzheimer’s research. The site is an Alzheimer’s Center of Excellence. In fact, its network has finished 5,500+ trials.
Visit Website →
New Hope Clinical Research
SouthPark, NC 28211 / 4+ active studies
Major Depression, Schizophrenia, Bipolar Disorder
Led by Dr. Kurian Abraham. It runs Phase I through IV studies and has 30 beds for overnight stays. Its last FDA audit came back clean. Also, it has finished 200+ brain studies.
Visit Website →
Queen City Clinical Research
SouthPark, NC 28211 / 2+ active studies
Chronic Pain, Chronic Migraine, Osteoarthritis
Led by Dr. Leonardo Kapural, a former Cleveland Clinic professor. Notably, he has written 200+ journal articles. On top of that, many call this the biggest pain research site in the country.
Visit Website →
Novant Health
Multiple Charlotte locations / Several active studies
Cardiovascular Disease, Obesity, Hypertension
One of the biggest health systems in the Carolinas. Its Heart and Vascular Institute runs heart studies and sees a lot of patients.
Visit Website →
DLVSC
4 Charlotte-area offices / 1+ active studies
Eczema, Psoriasis, Rosacea
Led by Dr. Gilly Munavalli. This award-winning skin practice owns 50+ FDA-approved lasers and devices. Also, it has its own research team.
Visit Website →
DelRicht Research
South Charlotte, NC 28210 / 1+ active studies
Bipolar Disorder, Bipolar Depression
Part of a national network of mental health research sites. Currently, it runs the azetukalner bipolar depression trial in Charlotte. Previously, it ran other mental health studies.
Visit Website →
TMS of the Carolinas
South Charlotte, NC 28210 / 1+ active studies
Major Depression, Treatment-Resistant Depression
A specialty site for brain stimulation care. It runs the fast TMS study that packs 6 weeks into 2.
Visit Website →What to Expect in a Hair Loss Study
New to studies? Here is how one works, step by step.
01
Prescreening
First comes a short phone call or online form. Also, it takes about 10 to 15 minutes. The staff check whether you might fit. Then they tell you what is open.
02
Screening Visit
Next the clinic runs the tests that decide it, which usually means blood work. Also, they go through the consent form line by line, and you can bring somebody with you.
03
Treatment Period
Then the study begins. So you take the study drug or the placebo on the agreed schedule. Meanwhile, your own doctor keeps managing everything else.
04
Follow-Up
Finally, there is a check in period at the end. Also, your own doctor gets the results, and you can stop at any point without affecting your care.
Hair Loss Trial FAQs
Real answers about alopecia and hair loss studies near Charlotte NC.
Is there a study for this near Charlotte?
Yes, four are open, though they take very different people. Two are for children and teenagers with the patchy kind, one from age six and one from age twelve. Another takes women only, aged 18 to 65, for gradual pattern thinning. Finally, a registry follows people already prescribed a hair loss tablet, and it gives no drug itself.
What is a SALT score?
It is the share of your scalp with hair missing, written as a percentage from 0 to 100. Most studies want 50 or more, which means at least half the scalp. So it is the single number that decides which studies will consider you. Notably, most people have never been told theirs, so ask for it in writing.
Is my hair loss the patchy kind or the thinning kind?
They are two different conditions, and it changes everything. The patchy kind comes out in smooth round circles, because the immune system attacks the follicle. Meanwhile, pattern hair loss thins gradually, usually along the parting or the crown. So ask your doctor to name which one you have before you look at any study.
Can hair actually grow back?
For the patchy kind, yes, and that is the important part. The follicle survives underneath, so it can restart even after years. However, regrowth is slow, because hair grows about half an inch a month at best. So these studies measure at six months and a year rather than at six weeks.
Will I get a dummy?
In most of these, yes, and the split is usually not published. However, the registry on this page has no dummy at all, because nothing is assigned in it. So ask each clinic what your actual odds are. Also, ask what happens at the end if you were in the dummy group.
Is it caused by stress?
Not on its own, and being told that is a common and frustrating experience. The patchy kind is an immune condition, where the body attacks its own hair follicles. Meanwhile, stress can trigger a flare in someone already prone to it. So it is a factor rather than the cause, and it does not mean nothing can be done.
Why do some studies stop at 63?
Because these tablets carry a warning about heart and clot risks. That warning came from a safety study in rheumatoid arthritis, in people over 50 who already had a heart risk factor. So the age ceilings are cautious rather than specific to hair loss. Notably, it is still the commonest reason an adult is turned away here.
Does it cost anything to check?
No. There is no cost, and no insurance is needed. Tether is a nonprofit list, so we do not run studies and we are not paid to send you anywhere. Also, checking never enrolls anyone in anything. You would always call the clinic yourself.
Where can I get help near Charlotte NC?
Atrium Health and Novant Health both run skin services across the metro, and several private dermatology practices run research here. Also, ask for a dermatologist rather than a general clinic, because the SALT score is theirs to give. Generally, your own doctor can check your thyroid and iron first. Meanwhile, both cause shedding and both are easily treated.
Ready to Explore a Study?
Check your eligibility, or just reach out to our Charlotte team. No pressure. Also, no sales pitch.
← Back to All Clinical TrialsSources
- Deuruxolitinib in teenagers, ClinicalTrials.gov NCT07133308
- BRAVE-AA-PEDS, baricitinib in children, ClinicalTrials.gov NCT05723198
- PRESTO, the ritlecitinib registry, ClinicalTrials.gov NCT06531109
- VDPHL01 in women with pattern hair loss, ClinicalTrials.gov NCT07146022
- Upadacitinib for severe patchy hair loss, ClinicalTrials.gov NCT06012240
Study details and per-site recruiting status verified against ClinicalTrials.gov on August 17, 2026. Every site row was read individually. A registry listed here returned nothing on either a state wide or a Charlotte search, and was found only by searching a smaller town directly. Two studies in this metro list a nearby site as no longer enrolling while the study overall still recruits, and one lists two sites in the same zip code with only one of them open. Study availability and criteria change; the research clinic confirms everything before you enroll.